Table 2.
Clinical evaluation of prostate lesions on mpMRI using PIRADSv2 and the multi-characteristic framework.
| Case # |
Age | PSA | Lesion | Index lesion |
Median PIRADSv2 score |
Framewor k result |
Histology result |
Overall performance Evaluation |
|---|---|---|---|---|---|---|---|---|
| 1 | 73 | 38.6 | 1 | Y | 5 | Positive | Gleason 4+5 | 4.7 |
| 2 | N | 1 | Positive | NA | ||||
| 2 | 71 | 7.63 | 1 | N | 1 | Positive | BPH | 3 |
| 2 | Y | 5 | Positive* | Gleason 4+5 | ||||
| 3 | N | 1 | Positive | BPH | ||||
| 4 | N | 1 | Positive | BPH | ||||
| 5 | N | 1 | Positive | NA | ||||
| 3 | 61 | 8.52 | 1 | Y | 5 | Positive | Gleason 3+4 | 4 |
| 2 | N | 4 | Positive | Gleason 3+3 | ||||
| 3 | N | 4 | Positive | Benign | ||||
| 4 | 55 | 5.05 | 1 | Y | 5 | Positive | Gleason 3+4 | 3.7 |
| 2 | N | 1 | Positive | Gleason 3+3 | ||||
| 3 | N | 1 | Positive | BPH | ||||
| 5 | 65 | 14.71 | 1 | Y | 5 | Positive | Gleason 4+5 | 4 |
| 6 | 54 | 35.55 | 1 | Y | 5 | Positive | Gleason 4+4 | 4.3 |
| 7 | 71 | 16.09 | 1 | Y | 5 | Positive | Gleason 4+5 | 4.7 |
| 2 | N | 5 | Positive | Gleason 4+5 | ||||
| 3 | N | 1 | Positive | Gleason 4+3 | ||||
| 8 | 78 | 43.18 | 1 | Y | 5 | Positive | Gleason 4+5 | 5 |
| 2 | N | 1 | Positive | NA | ||||
| 9 | 60 | 44.81 | 1 | Y | 5 | Positive | Gleason 4+4 | 4 |
| 2 | N | 1 | Positive | Benign | ||||
| 10 | 58 | 4.84 | 1 | Y | 5 | Positive | Gleason 4+3 | 4.3 |
| 2 | N | 1 | Positive | NA |